Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Suzuken CoTSE:9987 +3.28%79 Net Current Asset Value is 円2,014.86 as of Mar. 2026, which is 100% below its 10-year median of 2.61. GuruFocus rates TSE:9987 with a GF Score™ of 79/100 and a GF Value™ of 円5,918.83 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 75 Medical Distribution companies, Suzuken Co ranks better than 57.33% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Suzuken Co's net current asset value per share for the quarter that ended in Mar. 2026 was 円2,014.86.
The historical rank and industry rank for Suzuken Co's Net Current Asset Value or its related term are showing as below:
TSE:9987'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.93 Med: 2.61 Max: 3.93
Current: 2.56
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Suzuken Co was 3.93. The lowest was 1.93. And the median was 2.61.
TSE:9987's Price-to-Net-Current-Asset-Value is ranked better than 57.33% of 75
companies
in the Medical Distribution industry
Industry Median: 3.23
vs TSE:9987: 2.56
Suzuken Co (TSE:9987) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Suzuken Co Net Current Asset Value Related Terms
Suzuken Co Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Suzuken Co's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9987 vs MCK, CAH, COR: Net Current Asset Value Comparison
For the Medical Distribution subindustry, Suzuken Co's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Suzuken Co Price-to-Net-Current-Asset-Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Suzuken Co's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Suzuken Co's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of 円2,014.86 mean?
Suzuken Co (TSE:9987) has a Net Current Asset Value of 円2,014.86 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Suzuken Co and its competitors. This is 77098% above median its historical median of 2.61. Over the past decade, Suzuken Co's Net Current Asset Value has ranged from 1.93 to 3.93. According to the industry distribution chart, Suzuken Co ranks #32 out of 75 companies in the Medical Distribution industry, placing it in the top 42.7%.
Is Suzuken Co's Net Current Asset Value too high?
Suzuken Co's current Net Current Asset Value of 円2,014.86 is 77098% above median its 10-year median of 2.61. Over the past 10 years, this metric has ranged from a low of 1.93 to a high of 3.93. Based on the distribution chart, Suzuken Co ranks #32 out of 75 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Suzuken Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Suzuken Co's Net Current Asset Value compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Suzuken Co ranks #32 out of 75 companies for Net Current Asset Value. This puts Suzuken Co in the upper half of its industry. The industry median Net Current Asset Value is 3.23. Historically, Suzuken Co's own Net Current Asset Value has ranged from 1.93 to 3.93 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Distribution company?
The median Net Current Asset Value among Medical Distribution companies is 3.23, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Suzuken Co and its competitors. For the Medical Distribution industry, the median Net Current Asset Value is 3.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzuken Co's current Net Current Asset Value is 円2,014.86, which is 77098% above median its own 10-year median of 2.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzuken Co stock overvalued right now?
Based on GuruFocus' analysis, Suzuken Co (TSE:9987) is currently considered Modestly Undervalued. The stock's GF Value™ is 円5,918.83, compared to a current price of 円5,157.00 — trading 12.9% below its estimated fair value. The current Net Current Asset Value is 円2,014.86, which is 77098% above median its 10-year median of 2.61. Suzuken Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Suzuken Co (TSE:9987), the current Net Current Asset Value is 円2,014.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Suzuken Co (TSE:9987) Overvalued in 2026?
Based on GuruFocus' analysis, Suzuken Co stock appears to be undervalued.
The current stock price of 円5,157.00 is trading 12.9% below its estimated GF Value™ of 円5,918.83.
GuruFocus considers Suzuken Co to be Modestly Undervalued.
Key valuation signals for TSE:9987:
Net Current Asset Value: 円2,014.86 (77098% above median its 10-year median of 2.61)
GF Value™: 円5,918.83 vs. price of 円5,157.00 (12.9% below fair value)
No single metric tells the full story. See the TSE:9987 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Suzuken Co Ltd is engaged in the manufacture and sale of pharmaceuticals and medical devices, and in providing insurance, pharmacy, and nursing care services. The company operates through segments, including Pharmaceutical Wholesale business, Healthcare product development business, Specialty Pharmaceuticals Distribution business, Regional medical nursing care support business, and Medical-related Services business. It generates the majority of its revenue from the Pharmaceutical Wholesale Business segment, which sells prescription pharmaceuticals, diagnostic reagents, medical equipment, and medical supplies.
79GF Score
Get the complete analysis for TSE:9987
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9987 has been successfully added to your 
